Number of employees
Gerresheimer is a leading global partner to the pharma and healthcare industry and is located in Düsseldorf, Germany. The group is specialized in glass and plastic products that contribute to health and well-being. Gerresheimer operates worldwide and has about 10,000 employees that manufacture products for local markets, close to the company‘s customers.
Gerresheimer‘s plants in Europe, North America, South America and Asia generate revenues of approximately EUR 1.4 billion.
The product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, micro pumps, pre-fillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
Gerresheimers international business is split into three divisions:
Plastics & Devices
The product portfolio of this division includes customer-specific products for the simple and safe administration of medicines, such as insulin pens, inhalers and pre-fillable syringes. In addtion it includes diagnostics and medical technology products such as lancets and test systems, as well as pharmaceutical plastic containers for liquid and solid medicines with closure and safety systems. For the North American prescription retail market a complete line of regulatory compliant prescription containers for medication dispensing is available.
Primary Packaging Glass
This division produces glass primary packaging for medicines and cosmetics, such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars.
The acquisition of the Swiss technology company Sensile Medical laid the groundwork for this division, which is dedicated to developing and producing intelligent drug delivery systems. This division offers state-of-the-art digital and electronic technologies to pharmaceutical and biotech companies.
Products / Technology
Solutions for pharma and healthcare in glass and plastic
- Pharmaceutical primary packaging
- Drug delivery devices, medical and diagnostic products
- Mikro pumps
- Cosmetics and fragrances
- Food & beverage
- Nutritional supplements
- Life science
- 1864 - founded by Ferdinand Heye
- 1886 - With a production output of 45 million bottles Gerresheimer is the biggest bottle making plant in the world
- 1888 - Transformation into a joint stock company
- 1907 - first Owens machine on the European continent
- 1959 - Owens Illinois acquired a majority shareholding in Gerresheimer
- 1972 - Renaming of the company to Gerresheimer Glas AG
- 1958 - company headquarters moves from the Düsseldorf district of Gerresheim to another location in Düsseldorf
- 1987 - Development of tubing-based pharmaceutical glass product business
- 1991 - VIAG AG acquires a majority shareholding in Gerresheimer
- 1999 - Sale of the glass workse in Gerresheim
- 1999 - Sale of 6 companies and strategic reorientation to focus on pharmaceutical, laboratory, cosmetic and small glass products
- Regional expansion in the USA, Mexico and China
- 2000 - VIAG sold Gerresheimer to a private equity consortium
- New global organization structure
- 2006 - Take-over of Superfos Pharma A/S
- 2007 - New global organization structure to four divisions: Moulded Glass, Tubular Glass, Plastic Systems and Life Science Research
- Wilden AG take-over
- Gerresheimer AG is stock exchange listed
- Acquisition of the Spanish PET specialist EDP
- 2008 - Take-over of ALLPLAS Embalagens Ltda.
- Gerresheimer AG listed on MDAX
- 2009 - new R&D center opened in Peachtree City, Georgia, USA
- 2011 - acquisition of the Brazilian pharmaceutical plastic packaging manufacturer Védat
- 2012 - Medical Plastic Systems Division is further enlarged by the take-over of Münster-based item GmbH
- Majority shareholding in Neutral Glass & Allied Industries Pvt. Ltd
- Majority shareholding in Triveni, a leading manufacturer of pharmaceutical plastic packaging products and closures in India
- 2013 - The company regroups its operations into three divisions: Plastics & Devices, Primary Packaging Glass and Life Science Research
- 2015 - Centor take-over
- Sale of tubing operations to Corning
- 2016 - Sale of Life Science Research operations
- 2018 - Gerresheimer acquires Swiss technology company Sensile Medical and establishes new third Division Advanced Technologies
PETplanet Insider Articles
Issue 11 / 2021: Cosmetic portfolio made from ocean-bound PET